BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10964473)

  • 1. glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development.
    Paine-Saunders S; Viviano BL; Zupicich J; Skarnes WC; Saunders S
    Dev Biol; 2000 Sep; 225(1):179-87. PubMed ID: 10964473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome.
    Veugelers M; Vermeesch J; Watanabe K; Yamaguchi Y; Marynen P; David G
    Genomics; 1998 Oct; 53(1):1-11. PubMed ID: 9787072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the cell surface proteoglycan glypican-5 is developmentally regulated in kidney, limb, and brain.
    Saunders S; Paine-Saunders S; Lander AD
    Dev Biol; 1997 Oct; 190(1):78-93. PubMed ID: 9331333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simpson Golabi Behmel syndrome: progress toward understanding the molecular basis for overgrowth, malformation, and cancer predisposition.
    DeBaun MR; Ess J; Saunders S
    Mol Genet Metab; 2001 Apr; 72(4):279-86. PubMed ID: 11286501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling.
    Chiao E; Fisher P; Crisponi L; Deiana M; Dragatsis I; Schlessinger D; Pilia G; Efstratiadis A
    Dev Biol; 2002 Mar; 243(1):185-206. PubMed ID: 11846487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered hematopoiesis in glypican-3-deficient mice results in decreased osteoclast differentiation and a delay in endochondral ossification.
    Viviano BL; Silverstein L; Pflederer C; Paine-Saunders S; Mills K; Saunders S
    Dev Biol; 2005 Jun; 282(1):152-62. PubMed ID: 15936336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome.
    Pilia G; Hughes-Benzie RM; MacKenzie A; Baybayan P; Chen EY; Huber R; Neri G; Cao A; Forabosco A; Schlessinger D
    Nat Genet; 1996 Mar; 12(3):241-7. PubMed ID: 8589713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small interstitial deletion in the GPC3 gene causes Simpson-Golabi-Behmel syndrome in a Dutch-Canadian family.
    Xuan JY; Hughes-Benzie RM; MacKenzie AE
    J Med Genet; 1999 Jan; 36(1):57-8. PubMed ID: 9950367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPC6, a novel member of the glypican gene family, encodes a product structurally related to GPC4 and is colocalized with GPC5 on human chromosome 13.
    Paine-Saunders S; Viviano BL; Saunders S
    Genomics; 1999 May; 57(3):455-8. PubMed ID: 10329016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glypican-3 modulates inhibitory Bmp2-Smad signaling to control renal development in vivo.
    Hartwig S; Hu MC; Cella C; Piscione T; Filmus J; Rosenblum ND
    Mech Dev; 2005 Jul; 122(7-8):928-38. PubMed ID: 15925496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glypican-3 modulates BMP- and FGF-mediated effects during renal branching morphogenesis.
    Grisaru S; Cano-Gauci D; Tee J; Filmus J; Rosenblum ND
    Dev Biol; 2001 Mar; 231(1):31-46. PubMed ID: 11180950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene.
    Veugelers M; Cat BD; Muyldermans SY; Reekmans G; Delande N; Frints S; Legius E; Fryns JP; Schrander-Stumpel C; Weidle B; Magdalena N; David G
    Hum Mol Genet; 2000 May; 9(9):1321-8. PubMed ID: 10814714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome.
    Cano-Gauci DF; Song HH; Yang H; McKerlie C; Choo B; Shi W; Pullano R; Piscione TD; Grisaru S; Soon S; Sedlackova L; Tanswell AK; Mak TW; Yeger H; Lockwood GA; Rosenblum ND; Filmus J
    J Cell Biol; 1999 Jul; 146(1):255-64. PubMed ID: 10402475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haploinsufficient phenotypes in Bmp4 heterozygous null mice and modification by mutations in Gli3 and Alx4.
    Dunn NR; Winnier GE; Hargett LK; Schrick JJ; Fogo AB; Hogan BL
    Dev Biol; 1997 Aug; 188(2):235-47. PubMed ID: 9268572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma.
    Murthy SS; Shen T; De Rienzo A; Lee WC; Ferriola PC; Jhanwar SC; Mossman BT; Filmus J; Testa JR
    Oncogene; 2000 Jan; 19(3):410-6. PubMed ID: 10656689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overgrowth syndromes and genomic imprinting: from mouse to man.
    Li M; Squire JA; Weksberg R
    Clin Genet; 1998 Mar; 53(3):165-70. PubMed ID: 9630066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent silencing of the GPC3 gene in ovarian cancer cell lines.
    Lin H; Huber R; Schlessinger D; Morin PJ
    Cancer Res; 1999 Feb; 59(4):807-10. PubMed ID: 10029067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the heparan sulfate proteoglycan glypican-1 in the developing rodent.
    Litwack ED; Ivins JK; Kumbasar A; Paine-Saunders S; Stipp CS; Lander AD
    Dev Dyn; 1998 Jan; 211(1):72-87. PubMed ID: 9438425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noggin antagonism of BMP4 signaling controls development of the axial skeleton in the mouse.
    Wijgerde M; Karp S; McMahon J; McMahon AP
    Dev Biol; 2005 Oct; 286(1):149-57. PubMed ID: 16122729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor signaling regulates Dach1 expression during skeletal development.
    Horner A; Shum L; Ayres JA; Nonaka K; Nuckolls GH
    Dev Dyn; 2002 Sep; 225(1):35-45. PubMed ID: 12203718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.